Diabetes Clinical Trials in Tennessee

Showing 381-400 of 611 trials

Effect of Metabolic Control at Onset of Diabetes on Progression of Type 1 Diabetes

NCT00891995

The purpose of this study is to find out if very tight blood glucose control from the onset of Type 1 Diabetes can preserve beta cell function. Study subjects will be randomly assigned to receive either standard diabetes management or intensive diabetes management, which involves several days of closed loop therapy followed by home use of a continuous glucose monitor and insulin pump.

Type 1 Diabetes

Jaeb Center for Health Research71 participantsStarted Sep 2010

Stanford, California, United States • Aurora, Colorado, United States • New Haven, Connecticut, United States +2 more locations

COMPLETEDPhase 392 miles

Comparison of NN5401 Versus Insulin Glargine, Both Combined With Metformin Treatment, in Subjects With Type 2 Diabetes

NCT01045707

This trial is conducted in Asia, Europe and the United States of America (USA). The aim of this trial is to compare the efficacy and safety of NN5401 (insulin degludec/insulin aspart (IDegAsp)) with insulin glargine (IGlar), both as add-on to subject's ongoing treatment with metformin + at least one OAD (oral anti-diabetic drug). The main period is registered internally at Novo Nordisk as NN5401-3590 while the extension period is registered as NN5401-3726.

DiabetesDiabetes Mellitus, Type 2

Novo Nordisk A/S530 participantsStarted Jan 2010

Birmingham, Alabama, United States • Vestavia Hills, Alabama, United States • Concord, California, United States +89 more locations

Effect of Metabolic Control at Onset of Diabetes on Progression of Type 1 Diabetes

Comparison of NN5401 Versus Insulin Glargine, Both Combined With Metformin Treatment, in Subjects With Type 2 Diabetes

Diabetes Trials in Other Cities

A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.

A Study of Taspoglutide Versus Pioglitazone in Patients With Type 2 Diabetes

A Titration Study of a Glucagon-Like Peptide-1 (GLP-1) Analogue in Patients With Type 2 Diabetes Treated With Metformin.

A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease

A Dose-Titration Study of GK Activator (2) in Patients With Type 2 Diabetes.

A Study of a GLP-1 Analogue in Patients With Type 2 Diabetes Treated With Metformin.

A Study of Aleglitazar in Patients With Type 2 Diabetes

Adult Accuracy Study of the Enlite 3 Glucose Sensor

A Study to Evaluate the Efficacy and Safety of the Addition of Canagliflozin in Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin and Sitagliptin

T and B Cell Responses in Autoimmune Diseases

Connecting Smartphones With Electronic Health Record to Facilitate Behavioral Goal Monitoring in Diabetes Care

A Study of the Effect of Renal Impairment on the Activity of GK Activator (2) in Patients With Type 2 Diabetes.

A Drug-Drug Interaction Study of GK Activator (2) and Glyburide in Patients With Type 2 Diabetes.

Efficacy and Safety of Insulin Aspart vs. Human Insulin During Pregnancy by Women With Type 1 Diabetes

GLP-1 Receptor Agonist Lixisenatide (Morning or Evening) in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Metformin

Pharmacodynamic Study of the Effect of INCB013739 on Insulin Sensitivity in Obese, Type 2 Diabetic Subjects

A Multiple Ascending Dose Study of RO4998452 in Patients With Type 2 Diabetes Mellitus.

A Comparison of Atorvastatin and Glimepiride Fixed Dose Combination and Atorvastatin and Glimepiride Loose Combination in the Treatment of Patients With Type 2 Diabetes Mellitus

Other Conditions in Tennessee